• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化镁给药与草酸钙肾结石的预防

Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis.

作者信息

Khan S R, Shevock P N, Hackett R L

机构信息

Department of Pathology, College of Medicine, University of Florida, Gainesville 32610-0275.

出版信息

J Urol. 1993 Feb;149(2):412-6. doi: 10.1016/s0022-5347(17)36106-2.

DOI:10.1016/s0022-5347(17)36106-2
PMID:8426432
Abstract

We studied the effect of oral administration of magnesium oxide (MgO) on calcium oxalate (CaOx) nephrolithiasis in rats. Nephrolithiasis was induced by administration of 1.0% ethylene glycol (EG) in drinking water. Magnesium oxide was given mixed with food at 500 mg./100 g. rat chow. Dispensation of MgO resulted in a significant increase of urinary pH and a modest increase in urinary excretion of citrate. Urinary excretion of oxalate started to decline by day 14 and was significantly reduced on days 21 and 28. All rats receiving EG displayed crystalluria. From the group receiving EG only, 3 of 4 rats sacrificed on day 15 and 2 of 4 rats sacrificed on day 29 had CaOx crystal deposits in their kidneys. None of the 8 rats who received both EG and MgO had CaOx nephrolithiasis. Thus our findings indicate that dispensation of magnesium as MgO can be beneficial against calcium oxalate nephrolithiasis.

摘要

我们研究了口服氧化镁(MgO)对大鼠草酸钙(CaOx)肾结石形成的影响。通过在饮用水中给予1.0%的乙二醇(EG)诱导肾结石形成。将氧化镁与食物混合,按500毫克/100克大鼠饲料的比例给予。给予氧化镁导致尿pH值显著升高,尿枸橼酸盐排泄适度增加。草酸尿排泄在第14天开始下降,并在第21天和第28天显著减少。所有接受乙二醇的大鼠均出现晶体尿。仅接受乙二醇的组中,在第15天处死的4只大鼠中有3只,在第29天处死的4只大鼠中有2只在其肾脏中有草酸钙晶体沉积。接受乙二醇和氧化镁的8只大鼠中没有一只发生草酸钙肾结石。因此,我们的研究结果表明,以氧化镁形式给予镁对草酸钙肾结石可能有益。

相似文献

1
Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis.氧化镁给药与草酸钙肾结石的预防
J Urol. 1993 Feb;149(2):412-6. doi: 10.1016/s0022-5347(17)36106-2.
2
Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.口服柠檬酸钾钠和氧化镁预防尿路结石后尿参数的变化。
Urology. 2004 Jan;63(1):7-11; discussion 11-2. doi: 10.1016/j.urology.2003.09.057.
3
Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.乙二醇处理的大鼠肾脏中促进草酸钙晶体形成的尿液因子的品系差异。
Am J Physiol Renal Physiol. 2009 May;296(5):F1080-7. doi: 10.1152/ajprenal.90727.2008. Epub 2009 Feb 25.
4
Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.高草酸尿性草酸钙肾结石的模型构建:通过羟基-L-脯氨酸实验诱导高草酸尿症
Kidney Int. 2006 Sep;70(5):914-23. doi: 10.1038/sj.ki.5001699. Epub 2006 Jul 19.
5
Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.
J Urol. 1990 Feb;143(2):248-51. doi: 10.1016/s0022-5347(17)39924-x.
6
Effect of dietary calcium and magnesium on experimental renal tubular deposition of calcium oxalate crystal induced by ethylene glycol administration and its prevention with phytin and citrate.膳食钙和镁对乙二醇诱导的实验性肾小管草酸钙晶体沉积的影响及其用肌醇六磷酸和柠檬酸盐的预防作用。
Urol Int. 1987;42(5):330-7. doi: 10.1159/000281987.
7
Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats.通过多毛鼠麴草对大鼠实验性诱导肾结石进行草酸钙结石的预防。
BJU Int. 2003 Jul;92(1):137-40. doi: 10.1046/j.1464-410x.2003.04289.x.
8
The effects of the hydroalcohol extract of Rosa canina L. fruit on experimentally nephrolithiasic Wistar rats.狗蔷薇果水醇提取物对实验性肾结石形成 Wistar 大鼠的影响。
Phytother Res. 2012 Jan;26(1):78-85. doi: 10.1002/ptr.3519. Epub 2011 May 5.
9
Deposition of calcium phosphate and calcium oxalate crystals in the kidneys.磷酸钙和草酸钙晶体在肾脏中的沉积。
J Urol. 1995 Mar;153(3 Pt 1):811-7.
10
Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate.甘氨酸通过调节尿草酸和柠檬酸排泄抑制肾脏草酸钙晶体沉积。
J Cell Physiol. 2021 Oct;236(10):6824-6835. doi: 10.1002/jcp.30370. Epub 2021 Mar 27.

引用本文的文献

1
Dietary magnesium supplementation in cats with chronic kidney disease: A prospective double-blind randomized controlled trial.慢性肾脏病猫的膳食镁补充:一项前瞻性双盲随机对照试验。
J Vet Intern Med. 2024 Jul-Aug;38(4):2180-2195. doi: 10.1111/jvim.17134. Epub 2024 Jul 1.
2
How do stones form? Is unification of theories on stone formation possible?结石是如何形成的?结石形成理论有可能统一吗?
Arch Esp Urol. 2017 Jan;70(1):12-27.
3
[S2k guidelines on diagnostics, therapy and metaphylaxis of urolithiasis (AWMF 043/025) : Compendium].
[S2k 尿路结石诊断、治疗及群体预防指南(德国医学科学院 043/025):概要]
Urologe A. 2016 Jul;55(7):904-22. doi: 10.1007/s00120-016-0133-2.
4
Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.高草酸尿症诱导的肾小管缺血:维拉帕米对受影响肾脏抗氧化能力的影响。
Urolithiasis. 2016 Nov;44(6):509-519. doi: 10.1007/s00240-016-0894-5. Epub 2016 Jun 9.
5
Effect of magnesium on calcium and oxalate ion binding.镁对钙离子和草酸盐离子结合的影响。
J Endourol. 2013 Dec;27(12):1487-92. doi: 10.1089/end.2013.0173. Epub 2013 Oct 15.
6
Hyperoxaluria-induced tubular ischemia: the effects of verapamil and vitamin E on apoptotic changes with an emphasis on renal papilla in rat model.高草酸尿症诱导的肾小管缺血:维拉帕米和维生素E对凋亡变化的影响,重点关注大鼠模型中的肾乳头。
Urol Res. 2012 Feb;40(1):17-25. doi: 10.1007/s00240-011-0388-4. Epub 2011 May 24.
7
[Evidence-based pharmacological metaphylaxis of stone disease].[结石病的循证药理学预防]
Urologe A. 2006 Nov;45(11):1399-400, 1402-5. doi: 10.1007/s00120-006-1235-z.
8
Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.结石病的诊断与预防。结石病国家工作委员会针对即将出台的德国尿路结石指南的共识概念。
World J Urol. 2005 Nov;23(5):309-23. doi: 10.1007/s00345-005-0029-z. Epub 2005 Nov 29.
9
Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria.高草酸尿症诱导的肾小管细胞损伤中凋亡变化的局限性。
Urol Res. 2004 Aug;32(4):271-7. doi: 10.1007/s00240-003-0393-3. Epub 2004 Jul 13.